(Q34324837)

1 August 2017

1 reference

title

Aromatase inhibitors--mechanisms for non-steroidal inhibitors (English)

1 reference

1 August 2017

Vanden Bossche HV

1

1 reference

1 August 2017

Moereels H

series ordinal

2

1 reference

1 August 2017

Koymans LM

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Breast Cancer Research and Treatment

1 August 2017

published in

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

43-55

1 reference

Regulation of oestradiol 17 beta hydroxysteroid dehydrogenase in breast tissues: the role of growth factors

1 August 2017

cites work

1 reference

12 December 2020

Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones

1 reference

12 December 2020

Steroid Synthesis-Dependent, Oxygen-Mediated Damage of Mitochondrial and Microsomal Cytochrome P-450 Enzymes in Rat Leydig Cell Cultures*

1 reference

12 December 2020

Org 33201: a new highly selective orally active aromatase inhibitor

1 reference

12 December 2020

Aminoglutethimide: chemistry, pharmacokinetics, pharmacology and mechanism of action

1 reference

12 December 2020

Stereoselective inhibition of cholesterol side chain cleavage by enantiomers of aminoglutethimide

1 reference

12 December 2020

A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer

1 reference

12 December 2020

Aromatase in the human choriocarcinoma JEG-3: inhibition by R 76 713 in cultured cells and in tumors grown in nude mice

1 reference

12 December 2020

Basic studies on aminoglutethimide

1 reference

12 December 2020

CGEMA and VGAP: a Colour Graphics Editor for Multiple Alignment using a variable GAP penalty. Application to the muscarinic acetylcholine receptor

1 reference

12 December 2020

Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer

1 reference

12 December 2020

A phase I trial of CGS 16949A. A new aromatase inhibitor

1 reference

12 December 2020

Endocrine treatment of breast cancer in women

1 reference

12 December 2020

Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation

1 reference

12 December 2020

From 14 alpha-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells

1 reference

12 December 2020

Aminoglutethimide: review of pharmacology and clinical use.

1 reference

12 December 2020

The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cells in vitro

1 reference

12 December 2020

Brain mitochondrial cytochrome P-450scc: Spectral and catalytic properties

1 reference

12 December 2020

Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds

1 reference

12 December 2020

Inhibitors of steroidogenic enzymes for the treatment of breast cancer

1 reference

12 December 2020

Novel aromatase inhibitors

1 reference

12 December 2020

Acute Effects of Aminoglutethimide on Testicular Steroidogenesis in Normal Men*

1 reference

12 December 2020

Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones

1 reference

12 December 2020

Analogues of aminoglutethimide: selective inhibition of aromatase

1 reference

12 December 2020

Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women

1 reference

12 December 2020

Regulation of human aromatase cytochrome P450 gene expression.

1 reference

12 December 2020

Antiestrogen action in mammary cancer and in fetal cells

1 reference

12 December 2020

Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle

1 reference

12 December 2020

Catalytic efficiency of expressed aromatase following site-directed mutagenesis

1 reference

12 December 2020

Aminoglutethimide and glutethimide: effects on 18-hydroxycorticosterone biosynthesis by human and sheep adrenals in vitro

1 reference

12 December 2020

The significance of steroid metabolism in human cancer

1 reference

12 December 2020

Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids

1 reference

12 December 2020

Kinetic properties of aromatase mutants Pro308Phe, Asp309Asn, and Asp309Ala and their interactions with aromatase inhibitors

1 reference

12 December 2020

Expression of human placental aromatase in Saccharomyces cerevisiae

1 reference

12 December 2020

Endocrine treatment for breast cancers: biological rationale and current progress

1 reference

12 December 2020

Potential clinical role of new aromatase inhibitors

1 reference

12 December 2020

Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.

1 reference

12 December 2020

The expression of a functional cDNA encoding the chicken cytochrome P-450arom (aromatase) that catalyzes the formation of estrogen from androgen

1 reference

12 December 2020

Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients

1 reference

12 December 2020

Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors.

1 reference

12 December 2020

Inhibition of aromatase with CGS 16949A in postmenopausal women

1 reference

12 December 2020

Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects

1 reference

12 December 2020

Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease

1 reference

12 December 2020

Inhibitors of P450-dependent steroid biosynthesis: from research to medical treatment.

1 reference

12 December 2020

In vitro and in vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS 16949A.

1 reference

12 December 2020

The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis.

1 reference

12 December 2020

New non-steroidal aromatase inhibitors: focus on R76713.

1 reference

12 December 2020

Endogenous steroid hormones and local aromatase activity in the breast

1 reference

12 December 2020

Regulation of estrogen concentrations in human breast tissues

1 reference

12 December 2020

Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis

1 reference

12 December 2020

Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline

1 reference

12 December 2020

Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors

1 reference

12 December 2020

Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women

1 reference

12 December 2020

The involvement of human placental microsomal cytochrome P-450 in aromatization

1 reference

12 December 2020

Aromatase and its inhibitors--an overview

1 reference

12 December 2020

Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells

1 reference

12 December 2020

Potency and selectivity of the aromatase inhibitor R 76,713. A study in human ovarian, adipose stromal, testicular and adrenal cells

1 reference

12 December 2020

Structure-activity relationships and binding model of novel aromatase inhibitors

1 reference

12 December 2020

Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.

1 reference

12 December 2020

Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation

1 reference

12 December 2020

Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor

1 reference

12 December 2020

R 76713, a new specific non-steroidal aromatase inhibitor

1 reference

12 December 2020

R 76713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent oestrogen synthesis

1 reference

12 December 2020

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action

1 reference

12 December 2020

The importance of local synthesis of estrogen within the breast

1 reference

12 December 2020

Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity for N-alkyl derivatives

1 reference

12 December 2020

Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives

1 reference

12 December 2020

Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary

1 reference

12 December 2020

Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00682740

1 reference

Dimensions Publication ID

1 August 2017

1043023623

0 references

1 reference